Polycystic Kidney Disease 2-Like 1 (PKD2L1) (4th Cytoplasmic Loop) antibody

Details for Product No. ABIN350748
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Antigen
Synonyms PCL, PKD2L, PKDL, TRPP3, Pkdl, BC046386, B830002B15, PKD2L1, si:packtrz.2, si:xx-packtrz.2
Epitope
4th Cytoplasmic Loop
(5), (2), (2), (2), (1)
Reactivity
Human, Rat (Rattus), Mouse (Murine)
(11), (5), (4)
Host
Rabbit
(14), (1)
Clonality
Polyclonal
Application
Immunohistochemistry (IHC), Western Blotting (WB)
(13), (6), (2), (2), (1), (1)
Pubmed 6 references available
Catalog no. ABIN350748
Quantity 100 µL
Price
454.67 $   Plus shipping costs $45.00
Options
Shipping to United States (Change)
Availability Will be delivered in 7 to 8 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen A synthetic peptide from the 4th cytoplasmic loop of human PKD2L1 conjugated to an immunogenic carrier protein was used as the antigen.
Specificity Specific for SEPT2.
Purification whole serum
Alternative Name PKD2L1
Background This gene encodes a member of the polycystin protein family. The encoded protein contains multipletransmembrane domains, and cytoplasmic N- and C-termini. The protein may be an integral membrane protein involved in cell-cell/matrix interactions. This protein functions as a calcium-regulated nonselective cation channel. Alternative splice variants have been described but their full length sequences have not been determined
Function: May function as a subunit of an ion channel and act as a transducer of calcium-mediated signaling.
Subcellular location: Membrane, Multi-pass membrane protein.
Tissue specificity: Expressed in adult heart, skeletal muscle, brain, spleen, testis, retina and liver. According to Ref.1 expressed at high levels in fetal tissues, including kidney and liver, and down-regulated in adult tissues. It has been found to be expressed in fetal brain, but not expressed in fetal lung, liver or kidney. Isoform 4 appears to be expressed only in transformed lymphoblasts. Also known as: PK2L1, PKD2L1, PKD2L, PKDL, Polycystin-L.
UniProt P42208
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Restrictions For Research Use only
Format Liquid
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage -20 °C
Storage Comment Maintain the reconstituted antibodies frozen at -20 °C for long term storage and refrigerated at 2-8 °C for a shorter term.
Expiry Date 12 months
General Nomura, Turco, Pei et al.: "Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects." in: The Journal of biological chemistry, Vol. 273, Issue 40, pp. 25967-73, 1998 (PubMed).

Wu, Hayashi, Park et al.: "Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25." in: Genomics, Vol. 54, Issue 3, pp. 564-8, 1999 (PubMed).

Chen, Vassilev, Basora et al.: "Polycystin-L is a calcium-regulated cation channel permeable to calcium ions." in: Nature, Vol. 401, Issue 6751, pp. 383-6, 1999 (PubMed).

Veldhuisen, Spruit, Dauwerse et al.: "Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2)." in: European journal of human genetics : EJHG, Vol. 7, Issue 8, pp. 860-72, 2000 (PubMed).

Guo, Chen, Basora et al.: "The human polycystic kidney disease 2-like (PKDL) gene: exon/intron structure and evidence for a novel splicing mechanism." in: Mammalian genome : official journal of the International Mammalian Genome Society, Vol. 11, Issue 1, pp. 46-50, 2000 (PubMed).

Stayner, Zhou: "Polycystin channels and kidney disease." in: Trends in pharmacological sciences, Vol. 22, Issue 11, pp. 543-6, 2001 (PubMed).

Hosts (14), (1)
Reactivities (11), (5), (4)
Applications (13), (6), (2), (2), (1), (1)
Epitopes (5), (2), (2), (2), (1)
back to top